Antilipidemic Agent

Known as: Anti-lipidemic Agent 
An agent that reduces plasma lipids, such as cholesterol or low density lipoproteins (LDL), acting systemically or locally (intestines) to decrease… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1975-2016
012319752016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Rosuvastatin (RSVS), an anti-lipidemic agent suggested for the treatment of airway remodeling in chronic obstructive pulmonary… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2015
Review
2015
Curcumin (diferuloylmethane), a polyphenolic compound, is a component of Curcuma longa, commonly known as turmeric. It is a well… (More)
  • figure 1
Is this relevant?
2014
2014
OBJECTIVE To determine the effects of balanced deep-sea water (BDSW) on adipocyte hypertrophy and liver steatosis in high-fat… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Review
2012
Review
2012
In the recent years, the interest and research in medicinal plants have increased in a great deal. Ayurvedic medicines and… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Recent studies have demonstrated that n-3 polyunsaturated fatty acids ameliorate nonalcoholic fatty liver disease. Although… (More)
Is this relevant?
Review
2008
Review
2008
BACKGROUND The respective incidences of ischemic heart and cerebrovascular disease (IHD, CVD) are high in diabetic individuals… (More)
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Increased Aβ42 production has been linked to the development of Alzheimer disease. We now identify a number of compounds that… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2003
2003
We report 6-month results of renal allograft recipients enrolled in seven Australian centers as part of a worldwide, multicenter… (More)
Is this relevant?
1999
1999
The enantiomers of (+/-)-4-[1-(4-tert-butylphenyl)-2-oxo-pyrrolidine- 4-yl]methyloxybenzoic acid (S-2), a new antilipidemic agent… (More)
Is this relevant?
1997
1997
The effect of LDL-apheresis on the pharmacokinetics of antilipidemic agents has not been evaluated thoroughly. In this study, we… (More)
  • figure 2
  • figure 3
  • figure 5
Is this relevant?